{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:45:39Z","timestamp":1790358339690,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018524","name":"Kansas IDeA Network of Biomedical Research Excellence","doi-asserted-by":"publisher","award":["GMI03446"],"award-info":[{"award-number":["GMI03446"]}],"id":[{"id":"10.13039\/100018524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["E 01W81XWH2210981"],"award-info":[{"award-number":["E 01W81XWH2210981"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220646"],"award-info":[{"award-number":["RP220646"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170691"],"award-info":[{"award-number":["RP170691"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008527","name":"Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine","doi-asserted-by":"publisher","award":["P30 NCI-CA125123"],"award-info":[{"award-number":["P30 NCI-CA125123"]}],"id":[{"id":"10.13039\/100008527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R 24GMI37786"],"award-info":[{"award-number":["R 24GMI37786"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007137","name":"Texas Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016935","name":"Lisa Dean Moseley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012465","name":"Nemours Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002039","name":"CURE Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbc.2026.111390","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:19:44Z","timestamp":1774023584000},"page":"111390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling"],"prefix":"10.1016","volume":"302","author":[{"given":"Joshua R.","family":"Faust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Anders","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilkumar","family":"Gopalakrishnapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-3004","authenticated-orcid":false,"given":"Sonali P.","family":"Barwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111390_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111390_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111390_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040397","article-title":"Mesothelin expression in human tumors: a tissue microarray Study on 12,679 tumors","volume":"9","author":"Weidemann","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.111390_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10637-014-0196-0","article-title":"Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors","volume":"33","author":"Fujisaka","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jbc.2026.111390_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061550","article-title":"Mesothelin: an immunotherapeutic target beyond solid tumors","volume":"14","author":"Faust","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111390_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235964","article-title":"Immunotherapeutic targeting of Mesothelin positive pediatric AML using bispecific T cell engaging antibodies","volume":"13","author":"Gopalakrishnapillai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111390_bib7","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1158\/1078-0432.CCR-21-1546","article-title":"Therapeutic targeting of Mesothelin with chimeric antigen receptor T cells in Acute Myeloid Leukemia","volume":"27","author":"Le","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/blood-2024-204369","article-title":"Mesothelin targeting IL12-Engineered CAR memory-like NK cells demonstrate promising efficacy in Acute Myeloid leukemia","volume":"144","author":"Jang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111390_bib9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1158\/1541-7786.MCR-08-0095","article-title":"Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3","volume":"6","author":"Bharadwaj","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/carcin\/bgr075","article-title":"Mesothelin overexpression promotes autocrine IL-6\/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation","volume":"32","author":"Bharadwaj","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jbc.2026.111390_bib11","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/1078-0432.CCR-11-2614","article-title":"Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients","volume":"18","author":"Servais","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212443","article-title":"Host Mesothelin expression increases ovarian cancer metastasis in the peritoneal microenvironment","volume":"22","author":"Hilliard","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111390_bib13","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"Chen","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111390_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111390_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbc.2026.111390_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30584","article-title":"Children's oncology group's 2023 blueprint for research: myeloid neoplasms","volume":"70","author":"Cooper","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jbc.2026.111390_bib17","first-page":"530","article-title":"Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous Leukemia and Myelodysplastic Syndromes: guidelines from the American Society of transplantation and cellular therapy transplant","volume":"28","author":"Tarlock","year":"2022","journal-title":"Cell Ther."},{"key":"10.1016\/j.jbc.2026.111390_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood.2022016487","article-title":"Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report","volume":"141","author":"Turcotte","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111390_bib19","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1182\/bloodadvances.2021004424","article-title":"Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia","volume":"5","author":"Kaeding","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2026.111390_bib20","first-page":"1741","article-title":"Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer","volume":"19","author":"Inoue","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2026.111390_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100787","article-title":"The extracellular matrix: a key player in the pathogenesis of hematologic malignancies","volume":"48","author":"Sidhu","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.jbc.2026.111390_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123112","article-title":"Bone marrow microenvironment-induced chemoprotection in KMT2A rearranged pediatric AML is overcome by azacitidine-panobinostat combination","volume":"15","author":"Lehner","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111390_bib23","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1038\/s41598-020-65061-6","article-title":"ERK activity in immature leukemic cells drives clonal selection during induction therapy for Acute Myeloid leukemia","volume":"10","author":"Hayun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111390_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/BJ20110282","article-title":"Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK\/ERK and JNK pathways","volume":"442","author":"Chang","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111390_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.jbc.2026.111390_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12935-016-0314-5","article-title":"Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation","volume":"16","author":"Iriyama","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.111390_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.leu.2404547","article-title":"Lyn is an important component of the signal transduction pathway specific to FLT3\/ITD and can be a therapeutic target in the treatment of AML with FLT3\/ITD","volume":"21","author":"Okamoto","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111390_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2007-04-082099","article-title":"A critical role for Lyn in acute myeloid leukemia","volume":"111","author":"Dos Santos","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111390_bib29","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.21037\/tcr-24-1595","article-title":"Identification and functional analysis of GNAI1 as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia","volume":"14","author":"Liu","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081211","article-title":"GNAi2\/gip2-Regulated transcriptome and its therapeutic significance in ovarian cancer","volume":"11","author":"Ha","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2026.111390_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/10985549.2023.2285833","article-title":"Active Galpha(i\/o) mutants accelerate breast tumor metastasis via the c-Src pathway","volume":"43","author":"Lyu","year":"2023","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111390_bib32","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2014-12-619155","article-title":"Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A","volume":"125","author":"Zonta","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111390_bib33","first-page":"1450","article-title":"Bafetinib, a dual Bcr-Abl\/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia","volume":"11","author":"Santos","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jbc.2026.111390_bib34","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood-2005-06-2209","article-title":"NS-187, a potent and selective dual Bcr-Abl\/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia","volume":"106","author":"Kimura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111390_bib35","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111390_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2006.03.029","article-title":"Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery","volume":"247","author":"Scholler","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111390_bib37","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111390_bib38","first-page":"1","article-title":"Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats BMC","volume":"9","author":"Sathyanarayana","year":"2009","journal-title":"Struct. Biol."},{"key":"10.1016\/j.jbc.2026.111390_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091186","article-title":"Extracellular Matrix components and mechanosensing pathways in health and disease","volume":"14","author":"Berdiaki","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2026.111390_bib40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2026.111390_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042140","article-title":"Enhanced expression of glycolytic enzymes and succinate dehydrogenase complex flavoprotein subunit A by Mesothelin promotes glycolysis and mitochondrial respiration in myeloblasts of acute myeloid Leukemia","volume":"25","author":"Jang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111390_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41419-025-07653-6","article-title":"Mechanisms of chemotherapy failure in refractory\/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism","volume":"16","author":"Yeon Chae","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111390_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<75::AID-CNCR11>3.0.CO;2-#","article-title":"Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement","volume":"88","author":"Camera","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jbc.2026.111390_bib44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.21037\/tcr-23-587","article-title":"Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis","volume":"12","author":"Li","year":"2023","journal-title":"Transl Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib45","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1042\/BCJ20170582","article-title":"GPI-anchored proteins are confined in subdiffraction clusters at the apical surface of polarized epithelial cells","volume":"474","author":"Paladino","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111390_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1083\/jcb.200609174","article-title":"GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1","volume":"177","author":"Suzuki","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111390_bib47","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202006125","article-title":"High-speed single-molecule imaging reveals signal transduction by induced transbilayer raft phases","volume":"219","author":"Koyama-Honda","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111390_bib48","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6604964","article-title":"High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma","volume":"100","author":"Cheng","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111390_bib49","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.21037\/tcr-19-2027","article-title":"Level of mesothelin expression can indicate the prognosis of malignant pleural mesothelioma","volume":"9","author":"Feng","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111390_bib50","article-title":"MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells","volume":"10","author":"Hu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jbc.2026.111390_bib51","article-title":"MSLN correlates with immune infiltration and chemoresistance as a prognostic biomarker in ovarian cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2026.111390_bib52","article-title":"Mesothelin expression is correlated with chemoresistance in stage IV colorectal cancer","volume":"28","author":"Nagata","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbc.2026.111390_bib53","doi-asserted-by":"crossref","first-page":"11694","DOI":"10.18632\/oncotarget.3429","article-title":"High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis","volume":"6","author":"Thomas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111390_bib54","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/jcb.21785","article-title":"Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha","volume":"104","author":"Cooper","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jbc.2026.111390_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020394","article-title":"Addressing a pre-clinical pipeline gap: development of the pediatric Acute Myeloid Leukemia patient-derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine","volume":"12","author":"Stevens","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.111390_bib56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fonc.2016.00162","article-title":"Generation of pediatric leukemia xenograft models in NSG-B2m mice: Comparison with NOD\/SCID mice","volume":"6","author":"Gopalakrishnapillai","year":"2016","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2026.111390_bib57","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1182\/bloodadvances.2020001592","article-title":"CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia","volume":"4","author":"Quagliano","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2026.111390_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2026.111390_bib59","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2026.111390_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2026.111390_bib61","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111390_bib62","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jbc.2026.111390_bib63","series-title":"Pheatmap: Pretty Heatmaps","author":"Kolde","year":"2018"},{"key":"10.1016\/j.jbc.2026.111390_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jbc.2026.111390_bib65","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/s41467-018-07454-w","article-title":"Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry","volume":"9","author":"Searle","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111390_bib66","doi-asserted-by":"crossref","first-page":"25625","DOI":"10.1021\/acsomega.0c02564","article-title":"proteiNorm - a user-friendly tool for normalization and analysis of TMT and label-free protein quantification","volume":"5","author":"Graw","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jbc.2026.111390_bib67","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1021\/pr401264n","article-title":"Normalyzer: a tool for rapid evaluation of normalization methods for omics data sets","volume":"13","author":"Chawade","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.111390_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111390_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040628","article-title":"Modeling Down Syndrome myeloid leukemia by sequential introduction of GATA1 and STAG2 mutations in induced pluripotent stem cells with trisomy 21","volume":"11","author":"Barwe","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111390_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.omtm.2020.09.007","article-title":"Modeling transient abnormal myelopoiesis using induced pluripotent stem cells and CRISPR\/Cas9 technology","volume":"19","author":"Barwe","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbc.2026.111390_bib71","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:35:20Z","timestamp":1779838520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0021925826002607"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111390","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111390"}}